HR 2450 119th Congress House In Committee

Prescription Drug Transparency and Affordability Act

Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · Mar 27, 2025

View full text on Congress.gov ↗ Policy area: Health

Sponsor
Rep. McDonald Rivet, Kristen [D-MI-8]
Independent · MI
Cosponsors (3)
Rep. CarterRep. MenendezRep. James

Track HR 2450 in BallotBox360

Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.

Download on iOS Open Web App